HOME >> BIOLOGY >> NEWS
Vanderbilt's John Oates wins clinical research award

John A. Oates Jr., M.D., Thomas F. Frist Sr. Professor of Medicine and professor of Pharmacology at Vanderbilt University Medical Center, received the Sixteenth Annual Award of Excellence in Clinical Research from the General Clinical Research Centers Program April 17.

The award acknowledges outstanding clinical research, supported by the National Center for Research Resources of the National Institutes of Health.

The $5,000 award and certificate was conferred during the General Clinical Research Centers Program Directors meeting in Chicago. At the meeting, Oates delivered a lecture titled "Investigation on the Contribution of Cyclooxygenases to Human Disease."

"Dr. Oates is a legend in Clinical Research. He put Vanderbilt's clinical research on the map, and I was personally excited to propose him for this award, and gratified that others recognized, as we do, his enormous contributions," said Alastair Wood, M.D., associate dean of external affairs at Vanderbilt.

"There are several important features or characteristics of Vanderbilt that nurtured the research that went on here -- the intent of Vanderbilt Pharmacology to include human pharmacology within the scope of the academic mission of the department," Oates said. "Their commitment to it has brought strong basic science to bear on our clinical research. For the investigation of human pharmacology, this has been an ideal setting."

Oates said the Vanderbilt General Clinical Research Center has been recognized as one of the leading GCRC's in the United States, and a great asset to the Medical School.

"The General Clinical Research Center has provided essential resources for our research, initially under the leadership of Elliot Newman, and more recently, David Robertson," Oates said.

"Recently NIH leadership has rediscovered the importance of patient-oriented research and has taken a number of helpful steps to support it," Robertson said. "As attention has focused on the na
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
19-Apr-2004


Page: 1 2

Related biology news :

1. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
2. Matrisian named Vanderbilts first chair of cancer biology
3. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Innovative ceramic-on-metal hip replacements to undergo clinical trials
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. Warren Pharmaceuticals publishes results of preclinical evaluation
8. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
9. Scientists characterize new breast tumor subtypes with poor clinical outcomes
10. Uncertainty in clinical tests raises health care costs
11. Germany starts clinical development of a new tuberculosis vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... Iowa (PRWEB) , ... October 12, 2017 , ... ... based in Vilnius, Lithuania, announced today that they have entered into a multiyear ... is to provide CRISPR researchers with additional tools for gene editing across all ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
Breaking Biology Technology:
Cached News: